Check out recent PlatformQ Health News
Patients with rare diseases are anxious to find a cure, yet roughly only half ever receive a proper diagnosis. Many of these patients return to their primary care providers (PCPs) frustrated. There has often been little support available to PCPs looking to help these patients. That’s why the National Organization...
The growth of immunotherapies has shifted the standard of care for treating many solid tumors. As new indications are approved, there is a growing need for clinician education in this space. To that end, the Society for Immunotherapy of Cancer (SITC) and PlatformQ Health partnered to develop a two-part educational...
More than half of Americans face financial difficulties paying for medical treatment, according to a recent study. This is particularly relevant in rare diseases and cancer and exacerbates health issues while causing mounting anxiety. Many pharmaceutical companies have taken the lead in supporting patients in addressing these hurdles through online...
Clinicians Love Learning with PlatformQ Health
This activity has allowed me to better do a differential diagnosis between various neuropathies, some of them very similar in symptom presentation.
Clinician learners after participating in Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
After viewing these presentations, I can make use of more tools and alternatives to better explain their disease, and to talk with my patients about other treatment approaches.
Clinician learners after participating in AHA Conference Coverage Heart Failure Virtual Symposium (Clinical Spotlight on Novel Interventions for Patients with Heart Failure)
I am better at adjusting insulin therapy and individualizing the diabetic program for the patient.
Clinician, after participating in Long-acting Insulins In Treatment Of T2dm: Aligning Provider & Patient Perspectives To Address Therapeutic Barriers
I am more competent in prescribing the appropriate drugs. I also know how to involve my patients in health decisions to minimize non adherence.
Clinician, after participating in HIV Update: Adherence Advances with New ART Formulations
Leverage Our Learning Platform
Learn more about the PlatformQ Health Education solution and how to support CME/CE.